The studies provided do not actually investigate iron supplementation for energy or fatigue in humans, and none of the linked research directly addresses this topic. The included studies examine subjects such as estrogen and muscle function in muscular dystrophy mouse models, lactoferrin as a potential COVID-19 treatment, non-coding RNA in muscle growth, fMRI signal interpretation in the brain, and antiviral drug compounds — none of which constitute evidence for iron's role in energy metabolism or fatigue reduction. Research suggests that iron deficiency is broadly recognized in nutritional science as a contributor to fatigue and reduced exercise capacity, but that conclusion cannot be drawn from the studies provided here, and summarizing them as support for iron's effects on energy would misrepresent what the research actually shows. Readers interested in the evidence base for iron and fatigue should seek studies that directly examine iron status, supplementation, and relevant outcomes in human populations, as the available literature provided here does not speak to that question.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Loss of endogenous estrogen alters mitochondrial metabolism and muscle clock-... | Other | 2024 | Neutral | 85 |
| Lactoferrin as potential supplementary nutraceutical agent in COVID-19 patien... | Other | 2020 | Neutral | 80 |
| Network-based modelling reveals cell-type enriched patterns of non-coding RNA... | Other | 2024 | Neutral | 75 |
| BOLD signal changes can oppose oxygen metabolism across the human cortex | Other | 2023 | Neutral | 70 |
| Protoporphyrin IX and verteporfin prevent SARS-CoV-2 infection<i>in vitro</i>... | Other | 2020 | Neutral | 65 |